Location History:
- Eppstein, DE (2006)
- Idstein, DE (2007 - 2010)
- Wiesbaden, DE (2011 - 2014)
- Frankfurt-am-Main, DE (2012 - 2017)
Company Filing History:
10 out of 1,827 
10 out of 1,451 
3 out of 389 
Years Active: 2006-2017
Title: Marc Nazare: Innovative Mind in Pharmaceutical Research
Introduction:
In the world of pharmaceutical research and innovation, Marc Nazare has established himself as an accomplished inventor and patent holder. Hailing from Idstein, Germany, Nazare has contributed significantly to the development of valuable pharmacologically active compounds with wide-ranging applications in the treatment of various disorders. With an impressive portfolio of 23 patents, his work has made a significant impact on the field.
Latest Patents:
Among Nazare's latest patents, two notable inventions stand out. The first is focused on N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides, which have shown the ability to modulate protein kinase activity, particularly serum and glucocorticoid regulated kinase (SGK-1). These compounds have the potential for treating diseases associated with inappropriate SGK activity, such as degenerative joint disorders or inflammatory processes like osteoarthritis or rheumatism. The patent also includes processes for their preparation and pharmaceutical compositions comprising these compounds.
The second patent involves pyridine derivatives (formula I), which possess pharmacological properties necessary for treating conditions associated with pathological thrombus formation. These compounds function as antagonists of the platelet LPA receptor LPAR5 (GPR92), presenting opportunities for the treatment of cardiovascular disorders like thromboembolic diseases or restenosis. Similar to his previous patent, this invention includes processes for compound synthesis, their application as active ingredients in medicaments, and pharmaceutical compositions.
Career Highlights:
As an inventor, Nazare has worked with renowned pharmaceutical companies, including Sanofi-aventis Deutschland GmbH and Sanofi. Throughout his career, he has consistently demonstrated scientific excellence and an unwavering commitment to innovation. His extensive patent portfolio reflects his strong dedication to advancing pharmacological research and finding novel solutions to pressing medical challenges.
Collaborations:
Marc Nazare has had the privilege of collaborating with talented individuals in his field. Notably, he has worked alongside notable researchers and coworkers, namely Matthias Urmann and Volkmar Wehner. It is through these collaborative efforts that groundbreaking pharmaceutical advancements have been achieved, further solidifying Nazare's contributions to the scientific community.
Conclusion:
In the world of pharmaceutical innovations and patenting, Marc Nazare's extraordinary talents have driven significant advancements in the field. With his numerous patents, including the modulation of SGK activity and the treatment of disorders associated with thrombus formation, Nazare has demonstrated his skills and ambitions as a forward-thinking inventor. Through collaborations with esteemed colleagues and work in renowned pharmaceutical companies, his expertise continues to make a profound impact on the industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.